- Home
- PRZO vs GOVX Comparison
PRZO vs GOVX Comparison
Compare PRZO & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- GOVX
- Stock Information
- Founded
- PRZO 2014
- GOVX 2001
- Country
- PRZO Israel
- GOVX United States
- Employees
- PRZO N/A
- GOVX N/A
- Industry
- PRZO
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- GOVX Health Care
- Exchange
- PRZO Nasdaq
- GOVX Nasdaq
- Market Cap
- PRZO 6.5M
- GOVX 7.0M
- IPO Year
- PRZO 2023
- GOVX N/A
- Fundamental
- Price
- PRZO $0.54
- GOVX $3.42
- Analyst Decision
- PRZO
- GOVX Strong Buy
- Analyst Count
- PRZO 0
- GOVX 4
- Target Price
- PRZO N/A
- GOVX $14.00
- AVG Volume (30 Days)
- PRZO 380.3K
- GOVX 13.0M
- Earning Date
- PRZO 09-17-2024
- GOVX 08-06-2024
- Dividend Yield
- PRZO N/A
- GOVX N/A
- EPS Growth
- PRZO N/A
- GOVX N/A
- EPS
- PRZO N/A
- GOVX N/A
- Revenue
- PRZO $558,382.00
- GOVX $300,677.00
- Revenue This Year
- PRZO N/A
- GOVX N/A
- Revenue Next Year
- PRZO N/A
- GOVX $565.58
- P/E Ratio
- PRZO N/A
- GOVX N/A
- Revenue Growth
- PRZO N/A
- GOVX N/A
- 52 Week Low
- PRZO $0.49
- GOVX $1.09
- 52 Week High
- PRZO $3.59
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- PRZO 42.03
- GOVX 48.45
- Support Level
- PRZO $0.49
- GOVX $4.35
- Resistance Level
- PRZO $0.57
- GOVX $5.28
- Average True Range (ATR)
- PRZO 0.04
- GOVX 1.42
- MACD
- PRZO 0.00
- GOVX -0.57
- Stochastic Oscillator
- PRZO 47.87
- GOVX 30.59
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.